Announcements Archives

Hoffmann & Baron Prevails Before the Patent Trial and Appeal Board on Behalf of LEONHARD KURZ Stiftung & Co., KG

breakdance March 30, 2026 No Comments

Hoffmann & Baron successfully represented Patent Owner LEONHARD KURZ Stiftung & Co., KG (“KURZ”) in a post grant review proceeding (PGR2026-00011) before the U.S. Patent Trail and Appeal Board. In…

Hoffmann & Baron, LLP’s Attorney Alexandria P. Stiteler Serves as Panelist at Seton Hall Law School IP Careers Event

breakdance January 29, 2026 No Comments

Hoffmann & Baron, LLP is proud to announce that Alexandria P. Stiteler, who serves as Chair of the New Jersey Intellectual Property Law Association’s (NJIPLA) Mentorship Program, participated as a…

Hoffmann & Baron Obtains A Permanent Injunction and Attorney Fees for OSN Labs, LLC in a Trademark Infringement Litigation

breakdance February 2, 2024 No Comments

Hoffmann & Baron successfully enforced OSN Labs, LLC’s (“OSN”) BLACKOUT® trademark against Phoenix Energy, LLC (“Phoenix Energy”) in a trademark infringement, unfair competition, and false designation of origin litigation. Specifically,…

Hoffmann & Baron LLP Attends AgBio Innovators Tradeshow

breakdance August 25, 2023 No Comments

Hoffmann & Baron, LLP recently attended the AgBio Innovators Tradeshow in Danville, VA. The conference included collaborative panels, small- and large-scale research, diverse funding and commercialization. Agriculture was the first…

Hoffmann & Baron LLP Welcomes Alexandria Stiteler

breakdance September 21, 2022 No Comments

Hoffmann & Baron is excited to welcome Alexandria Stiteler to the firm. She is a recent cum laude graduate from St. John’s University School of Law and holds a bachelor’s…

Hoffmann & Baron LLP Welcomes Curtis Altmann, JD, Ph.D.

breakdance July 21, 2022 No Comments

The firm is pleased and excited to welcome Curtis R. Altmann, JD, Ph.D., as a Partner at the DC office. Curtis’ practice is largely focused on worldwide patent prosecution, opinions…

Welcome Matthew Solow and Andrea Wilkovich To The Partnership

breakdance May 12, 2022 No Comments

Hoffmann & Baron is delighted to welcome Matthew Solow and Andrea Wilkovich to the partnership. They have both established themselves as integral members of the firm with their high work…

Hoffmann & Baron Prevails Before The Federal Circuit On Behalf Of Aquestive Therapeutics, Inc.

breakdance October 19, 2021 No Comments

Neurelis, Inc.’s US Patent No. 9,763,876 (“the ‘876 patent”) is listed in the FDA’s “Orange Book” under Neurelis’ Valtoco® product (diazepam nasal spray). Neurelis had appealed the PTAB’s August 6,…

Hoffmann & Baron LLP Welcomes Joseph W. Ricigliano, JD, Ph.D.

breakdance June 16, 2021 No Comments

Hoffmann & Baron, LLP is pleased to announce that Joseph W. Ricigliano, JD, Ph.D., has joined the firm as a Partner on June 14, 2021; Joe will be responsible for…

U.S. Supreme Court Denies BDSI’s Petition for Certiorari Seeking to Require the U.S. PTAB to Reconsider Decision to Not Institute Inter Partes Reviews of Aquestive’s U.S. Patent No. 8,765,167, as Drafted/Prosecuted/Defended By Hoffmann & Baron

breakdance October 14, 2020 No Comments

Aquestive Therapeutics, Inc.’s U.S. Patent No. 8,765,167 (“Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions”) is a cornerstone of Aquestive’s PharmFilm® rapidly-dissolving, thin-film pharmaceutical technology; the ‘167 Patent was…

Library Post Type: Announcements

Hoffmann & Baron Prevails Before the Patent Trial and Appeal Board on Behalf of LEONHARD KURZ Stiftung & Co., KG

Hoffmann & Baron, LLP’s Attorney Alexandria P. Stiteler Serves as Panelist at Seton Hall Law School IP Careers Event

Hoffmann & Baron Obtains A Permanent Injunction and Attorney Fees for OSN Labs, LLC in a Trademark Infringement Litigation

Hoffmann & Baron LLP Attends AgBio Innovators Tradeshow

Hoffmann & Baron LLP Welcomes Alexandria Stiteler

Hoffmann & Baron LLP Welcomes Curtis Altmann, JD, Ph.D.

Welcome Matthew Solow and Andrea Wilkovich To The Partnership

Hoffmann & Baron Prevails Before The Federal Circuit On Behalf Of Aquestive Therapeutics, Inc.

Hoffmann & Baron LLP Welcomes Joseph W. Ricigliano, JD, Ph.D.

U.S. Supreme Court Denies BDSI’s Petition for Certiorari Seeking to Require the U.S. PTAB to Reconsider Decision to Not Institute Inter Partes Reviews of Aquestive’s U.S. Patent No. 8,765,167, as Drafted/Prosecuted/Defended By Hoffmann & Baron

OFFICES